Panacea Biotec Pharma Limited Tacrolimus Export Data — India (DGFT 2022–2026)

Name: Panacea Biotec Pharma Limited Tacrolimus Export Records India — #5 Exporter, 103 Shipments, $5.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tacrolimus

India Pharmaceutical Trade Intelligence

$201.2M299 Suppliers127 CountriesHS 30049099

ExportsIndia → UNITED STATES54.1%India → SLOVENIA11.9%

ImportsIRELAND → India$38.9M GERMANY → India$3.6M

#1 Supplier: SANDOZ PRIVATE #1 Buyer: ASCEND LABORATORIES

Panacea Biotec Pharma Limited — Tacrolimus Exporter #5 | $5.2M Trade Value | TransData Nexus | TransData Nexus

Panacea Biotec Pharma Limited — Tacrolimus Exporter Profile

Indian Pharmaceutical Exporter · #5 for Tacrolimus · $5.2M export value · DGFT Verified

Panacea Biotec Pharma Limited is the #5 Indian exporter of Tacrolimus with $5.2M in export value and 103 verified shipments. Panacea Biotec Pharma Limited holds a 2.6% market share in Tacrolimus exports across 19 countries. The company exports 13 pharmaceutical products worth $23.9M across 9 therapeutic categories.

Panacea Biotec Pharma Limited — Tacrolimus Export Profile: Buyers & Destinations

Panacea Biotec Pharma Limited Tacrolimus export treemap — buyers and destination countries | TransData Nexus

Where Does Panacea Biotec Pharma Limited Export Tacrolimus?

Country	Value	Shipments	Share
TRINIDAD & TOBAGO	$352.3K	15	16.4%
MYANMAR	$266.9K	11	12.4%
KENYA	$264.2K	7	12.3%
SRI LANKA	$169.4K	15	7.9%
PHILIPPINES	$149.3K	3	6.9%

Who Are the Top Buyers of Tacrolimus from Panacea Biotec Pharma Limited?

Buyer	Country	Value	Orders
THE NATIONAL INSURANCE PROPERTY DEV	TRINIDAD & TOBAGO	$346.3K	12
PRIME BANK LTD	KENYA	$150.0K	3
CAMBER FARMACEUTICA LTDA	BRAZIL	$138.5K	7
AP SCOTT TRINIDAD LTD	TRINIDAD TOBAGO	$124.2K	6
RIGHT & BRIGHT INTERNATIONAL COMPAN	MYANMAR	$116.9K	8
PRIME BANK LIMITED	KENYA	$106.1K	3
NUTRAVIT SAL OFFSHORE DAGHER	LEBANON	$100.0K	2
RIGHT BRIGHT INTERNATIONAL COMPAN	MYANMAR	$100.0K	2
DEGA INTERNATIONAL PHARMA CORP RM	PHILIPPINES	$99.3K	2
MCKESSON SPECIALTY CARE DISTRIBUTIO	UNITED STATES	$74.4K	3

Panacea Biotec Pharma Limited supplies Tacrolimus to 36 buyers globally. The largest buyer is THE NATIONAL INSURANCE PROPERTY DEV (TRINIDAD & TOBAGO), followed by PRIME BANK LTD (KENYA) and CAMBER FARMACEUTICA LTDA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Tacrolimus Formulations Does Panacea Biotec Pharma Limited Export?

Product Description / Formulation	Value	Shipments
PANGRAF 1.0 MG CAPSULES (EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENT TO ANHYDROUS TACROLIMUS 1.0 MG) B/N.30	$324.7K	19
TACROLIMUS CAPSULES 5.0 MG (EACH CAPSULE	$200.0K	4
PANGRAF 1 0 MG CAPSULES EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENT TO ANHYDROUS TACROLIMUS 1 0 MG B N 30	$189.0K	4
TACROLIMUS CAPSULES 1.0 MG (EACH CAPSULE	$184.0K	5
PANGRAF 1.0 MG CAPSULES EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENT TO ANHYDROUS TACROLIMUS 1.0 MG B/N.30	$171.2K	5
TACROLIMUS CAPSULES 1.0 MG (EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENT TO ANHYDROUS TACROLIMUS 1.0 MG) PAN	$107.2K	4
SOLID DISPERSION OF TACROLIMUS B/N.800123001 M/D.04/2023 E/D.03/2025.	$100.0K	2
TAGRAF 1.0 MG CAPSULES EACH HARD GELATINCAPSULE CONTAINS TACROLIMUS EQUIVALENTTO ANHYDROUS TACROLIMUS 1.0 MG B/N.96023	$99.3K	2
TACROLIMUS CAPSULES 1.0 MG (EACH CAPSULECONTAINS TACROLIMUS USP ...1.0 MG) (TACROFORT 1.0) B/N.300224001 TO 300224007 M	$91.9K	3
PANGRAF 1.0 MG CAPSULES EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENTTO ANHYDROUS TACROLIMUS 1.0 MG B/N.3041	$54.5K	2

Panacea Biotec Pharma Limited exports 42 distinct Tacrolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PANGRAF 1.0 MG CAPSULES (EACH HARD GELATIN CAPSULE CONTAINS with 19 shipments worth $324.7K.

How Does Panacea Biotec Pharma Limited Compare to Nearest Tacrolimus Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	INTAS PHARMACEUTICALS LIMITED	$22.5M	588	13	$38.2K
2	ALKEM LABORATORIES LIMITED	$8.4M	168	3	$50.0K
5	PANACEA BIOTEC PHARMA LIMITED ★	$5.2M	103	19	$50.0K
6	DR.REDDY'S LABORATORIES LTD	$4.2M	84	4	$50.0K
8	STRIDES PHARMA SCIENCE LIMITED	$3.5M	69	6	$50.0K

Panacea Biotec Pharma Limited ranks #5 among 299 Indian Tacrolimus exporters. Average shipment value of $50.0K compared to the market average of $309.1K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and ALKEM LABORATORIES LIMITED.

Which Indian Ports Ship Tacrolimus Exports?

Port	Shipments	% Share
SAHAR AIR	741	16.1%
SAHAR AIR CARGO ACC (INBOM4)	645	14.0%
DELHI AIR CARGO ACC (INDEL4)	398	8.6%
NHAVA SHEVA SEA (INNSA1)	358	7.8%
DELHI AIR	320	6.9%
AHEMDABAD AIR ACC (INAMD4)	175	3.8%
JNPT/ NHAVA SHEVA SEA	169	3.7%
Bombay Air	141	3.1%

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Tacrolimus Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Panacea Biotec. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential delays. These maritime disruptions are particularly concerning for time-sensitive pharmaceutical shipments, as extended transit times and congestion elevate the risk of cold-chain failures for vaccines and biologics. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced uncertainties for Indian exporters. While health products have been exempt from U.S. tariffs, there is growing concern that this exemption may not be permanent. The potential imposition of tariffs on pharmaceutical imports could impact Panacea Biotec's profitability, given the company's significant export volume to the U.S. market. (lemonde.fr)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. This shift presents an opportunity for Panacea Biotec to expand its footprint in the U.S. market, provided it can navigate the evolving regulatory and trade environment effectively.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The recent GMP non-compliance issue at Panacea Biotec's Baddi facility underscores the importance of adhering to stringent EU regulations. Addressing these compliance challenges promptly is essential to maintain and grow the company's presence in European markets.

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency (EMA) enforcing stringent quality standards. For Indian exporters, maintaining compliance with these standards is paramount to ensure uninterrupted market access.

Panacea Biotec's recent GMP non-compliance at its Baddi facility highlights the critical need for robust quality management systems. The company has committed to implementing comprehensive corrective and preventive actions and plans to request a re-inspection to reinstate its GMP certificates. (prysm.fi) Proactive measures in quality assurance will be vital for Panacea Biotec to rebuild trust with regulatory bodies and international clients.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tacrolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Panacea Biotec Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 115 individual customs records matching Panacea Biotec Pharma Limited exporting Tacrolimus, covering 42 formulations to 22 countries via 36 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 127+ countries, 727+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tacrolimus

Tacrolimus

Panacea Biotec Pharma Limited — Tacrolimus Exporter Profile

Panacea Biotec Pharma Limited — Tacrolimus Export Profile: Buyers & Destinations

Where Does Panacea Biotec Pharma Limited Export Tacrolimus?

Who Are the Top Buyers of Tacrolimus from Panacea Biotec Pharma Limited?

What Is India's Total Tacrolimus Export Value and How Much Does Panacea Biotec Pharma Limited Contribute?

What Is the Average Shipment Value for Panacea Biotec Pharma Limited's Tacrolimus Exports?

How Does Panacea Biotec Pharma Limited Compare to Other Indian Tacrolimus Exporters?

What Tacrolimus Formulations Does Panacea Biotec Pharma Limited Export?

How Does Panacea Biotec Pharma Limited Compare to Nearest Tacrolimus Exporters?

Which Indian Ports Ship Tacrolimus Exports?

What Other Immunosuppressants Products Does Panacea Biotec Pharma Limited Export?

Tacrolimus — Export Intelligence Video

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Tacrolimus Exports

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

About Panacea Biotec Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tacrolimus Export Data from Panacea Biotec Pharma Limited

Tacrolimus Stats

Company Overview

Top Products by Panacea Biotec Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source